The drug combination<unk>  (INNs, trade names Tekamlo and Rasilamlo) is an antihypertensive. Clinical trials have shown it to be more effective than<unk>  on its own, with a high dosing regime<unk>  300 mg/amlodipine 10 mg) being more effective than olmesartan/amlodipine with comparable tolerability.
Aliskiren/amlodipine
Olmesartan/amlodipine
Telmisartan/amlodipine
Olmesartan/hydrochlorothiazide
Hydrochlorothiazide/triamterene
Lisinopril/amlodipine
Aliskiren/hydrochlorothiazide
Telmisartan/hydrochlorothiazide